Press Releases

March 2021

Intrommune Therapeutics Names Chief Operating Officer

March 2021

Research Presentations at the 2021 Annual AAAAI Meeting Highlight Limitations of Current Food Allergy Treatments and Further Validates Intrommune Therapeutics’ Approach

February 2021

Intrommune Therapeutics Publishes Peanut Allergy and Immunotherapy Report

February 2021

Intrommune Receives IND Clearance From U.S. Food and Drug Administration for INT301

October 2020

Intrommune Therapeutics Strikes Deal with Circuit Clinical®

October 2020

Recent Peer-Reviewed Publication Supports Immunotherapy for the Treatment of Food Allergies

September 2020

Media Alert: Interest in Peanut Allergy Market Heats up in the Wake of Aimmune/Nestlé Deal

February 2020

Survey Confirms Physician Interest in Peanut Allergy Immunotherapy

January 2020

Intrommune Presenting at Biotech Showcase 2020